The 15th China Chest Pain Centers Congress (CCPCC2026) will be jointly held in Hong Kong and Shenzhen on April 3–4, 2026. The "Forum on New Advances in Cardiovascular Diagnosis and Treatment" brings together leading cardiovascular experts from the Chinese mainland and Hong Kong. Over two days and seven sessions, we’ ll map out the present and future of cardiovascular care, spanning molecular biomarkers, device innovation, invasive diagnostics, and non-invasive imaging. The forum aims to help clinicians see sharper, treat smarter, and manage better.

Forum Name: Forum on New Advances in Cardiovascular Diagnosis and Treatment

Venue:

April 3: Hong Kong Convention and Exhibition Centre (S224+S225)

April 4: The Hall 18, Shenzhen World (CC105A)

【Forum Schedule】

Friday, April 3

•11:00-12:00 | Session 1

•13:30-15:30 | Session 2

•15:30-17:30 | Session 3

Saturday, April 4

•08:30-10:30 | Session 4

•10:30-12:30 | Session 5

•13:30-15:30 | Session 6

•15:30-17:30 | Session 7

Q&A | Your Top 3 Questions Answered!

Q1: In my daily practice, I often run into tricky cases: angiography shows "non-obstructive" lesions, yet the patient has clear angina. Or someone shows up with chest pain, and standard tests can't pin down the cause. For these "invisible" lesions, what new tools or perspectives can this forum offer?

A1: And that's exactly what this forum's diagnostic track is designed to tackle. Session 1 focuses on invasive diagnostics, spotlighting microvascular dysfunction as the hidden culprit behind unexplained symptoms. We'll also dive into intravascular imaging for precise plaque assessment, and how OCT is transforming acute coronary syndrome (ACS) interventions. Think of it as giving interventional cardiologists a "third eye."

Session 2 shifts to non-invasive tools: the latest in CT for coronary disease, clinical value of cardiac troponin fragments, inflammatory markers in ACS prognosis, and how pericoronary fat and metabolites reveal vascular function. From imaging to molecular markers, bringing the diagnostic frontier forward.

Q2: With complex lesions, acute cases, and a flood of new devices and drugs, I sometimes feel I'm struggling to keep up with treatment decisions. How will this forum help clinicians stay on top of evolving strategies?

A2: We're entering an era of precision-driven cardiology, and our program reflects that, from mechanism to management.

•For coronary artery disease: We'll walk through the latest on antiplatelet therapy post-PCI, new horizons in lipid-lowering for ACS, and what a "no-implant" future could look like.

•For heart failure & cardiomyopathies: Tough clinical questions get airtime—like managing obstructive HCM, treating HFrEF with hypotension, and device-based HF therapies.

•For structural heart disease: Experts from home and abroad will share real-world experience and the latest devices for LAAC, aortic regurgitation interventions, and transcatheter edge-to-edge valve repair.

Notably, the forum will also feature dedicated sessions on topics such as "Driving Chinese Medical Innovation Based on Clinical Needs," "Gene Therapy," and "Targeted Lipid-Lowering", helping physicians broaden their perspectives and understand new targets and pathways previously difficult to access with traditional approaches.

Q3: I come from a primary care hospital, and my daily work primarily involves managing common diseases and chronic conditions. The forum topics seem very cutting-edge and advanced. What benefits could attending the conference bring to someone like me?

A3: Cutting-edge progress is not unrelated to primary care; in fact, primary care physicians play an irreplaceable role in prevention, screening, and long-term disease management.

Discussions on non-invasive imaging and biomarkers can assist primary care clinicians in determining the optimal timing for referrals, thereby enhancing the efficiency of the tiered diagnosis and treatment system. Interpretations of documents like the "Chest Pain Center Antithrombotic Management Flowchart" and "Advances in ACS Lipid-Lowering Therapy" directly inform daily prescription decisions. Insights into inflammatory markers and mechanisms of atherosclerosis deepen the understanding of disease pathology, empowering clinicians to provide more effective guidance on patient lifestyle interventions and long-term health management.

We believe that colleagues from any practice setting will find valuable insights and inspiration at this forum.

The upcoming "Forum on New Advances in Cardiovascular Diagnosis and Treatment" rejects abstract, ivory-tower discussions, focusing squarely on genuine clinical pain points. Whether you are a cardiologist, radiologist, professional involved in Chest Pain Center construction, or a primary healthcare worker, this forum offers new knowledge, technologies, and strategies worthy of your attention. We look forward to joining you for this "Innovation Rendezvous" in the cardiovascular field at the 15th China Chest Pain Centers Congress on April 3-4.